US Biotech Stock Shows High Growth Potential in Alzheimer's Research

A US biotech company focused on Alzheimer's and dementia research is projected by experts to have a 190% stock growth potential if it makes progress in its fight against these major diseases.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

die-presseGerman65d ago

Demenzforschung als Geschäft: Diese Biotech-Aktie hat laut Experten 190 Prozent Kurspotenzial [premium]

Viele Firmen haben sich dem Kampf gegen die großen Krankheiten der Gegenwart verschrieben. Dieses US-Unternehmen forscht im Bereich Alzheimer und Demenz. Bei Fortschritten würde die Aktie laut Experten explodieren.

Read full article →

PERSPECTA

PERSPECTA

US Biotech Stock Shows High Growth Potential in Alzheimer's Research

Sources

Demenzforschung als Geschäft: Diese Biotech-Aktie hat laut Experten 190 Prozent Kurspotenzial [premium]

Related Stories

This vote to sell family shares has been open since …

Paramount Seeks $1.88 Billion Bond in Merger Lawsuit

Russian Economist Fired After Comparing Economy to 1917; Nestle Assets Targeted

Chelsea Chairman Boehly Considers Selling Stake to Clearlake Capital

PERSPECTA